Technology | January 31, 2013

Bionix Radiation Therapy introduces Accu-Tatt Tattooing System

Bionix Radiation Therapy Acu-Tatt Patient Positioning

January 31, 2013 — Accu-Tatt is an easy-to-use, sterile, all inclusive tattooing device designed to permanently mark radiation therapy patients. Every Accu-Tatt pouch conveniently contains an ink ampoule and a ¾-inch, 22-gauge needle. Packaging the needle and ampoule in a sterilized pouch reduces the concern for contamination and cross-contamination within radiation therapy facilities. In addition, Accu-Tatt’s short needle length allows for increased control while tattooing the patient. The Accu-Tatt shell contains an ampoule filled with sterile black ink. To start the flow of ink, hold the ampoule upright in one hand and use the thumb to bend the shell, breaking the ampoule. The end of the ampoule houses a luer lock fitting to accommodate the prepackaged, sterilized hypodermic needle.

Twenty-five individually wrapped Accu-Tatt systems will be packaged together in a dispensing box. Each pouch, containing the needle and ampoule, is sterilized.

Permanent tattoos are used during radiation therapy to mark the edge of the treatment field. These permanent markings help ensure the reproducibility of the patient throughout the treatment cycle.

The product is available now for immediate purchase.

For more information: www.bionixrt.com

Related Content

With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.
RefleXion Medical, Inc., a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT) as a new modality that will one day treat all stages of cancer,announced the sale of its RefleXion X1 machine to The Center for Cancer and Blood Disorders, a free-standing cancer treatment center with 15 locations throughout northern Texas.

RefleXion Medical announces the sale of its X1 machine to The Center for Cancer and Blood Disorders in Texas. (Photo: Business Wire)

News | Radiation Therapy | August 23, 2021
August 23, 2021 — ...
The global radiotherapy market is forecasted to reach USD 7987.01 Million in the year 2020, according to the "Global Radiotherapy Market - Analysis By Procedure (External Radiation, Internal Radiation), Product, Application, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)" report from ResearchAndMarkets.com
News | Radiation Therapy | August 20, 2021
August 20, 2021 — The global radiotherapy market is forecasted to reach $8.29 billion in the year 2021, according to